Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

DO MULTIPLE ADMINISTRATIONS OF STABLE IODINE PROTECT POPULATION CHRONICALLY EXPOSED TO RADIOACTIVE IODINE: WHAT IS PRIODAC RESEARCH PROGRAM (2014-22) TEACHING US?

Abstract : Single dose of potassium iodide (KI) is recommended to prevent the risk of thyroid cancer during nuclear accidents. However in the case of repeated/protracted radioiodine release, a unique dose of KI may not protect efficiently the thyroid against the risk of further developing a radiation-induced cancer. The new WHO guidelines for the use in planning for and responding to radiological and nuclear emergencies identify the need of more data on this subject as one of the four research priorities. The aims of the PRIODAC project are (1) to assess the associated side effects of repeated intakes of KI, (2) to better understand the molecular mechanisms regulating the metabolism of iodine, (3) to revise the regulatory French marketing authorization of 65-mg KI tablets and (4) to develop new recommendations related to the administration of KI toward a better international harmonization. A review of the literature and the preliminary data are presented here.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal-amu.archives-ouvertes.fr/hal-02067478
Déposant : Administrateur Hal Amu <>
Soumis le : jeudi 14 mars 2019 - 11:42:08
Dernière modification le : mardi 13 octobre 2020 - 03:10:53

Identifiants

Citation

Marc Benderitter, Thierry Pourcher, Jean-Charles Martin, Jacques Darcourt, Pierre Guigon, et al.. DO MULTIPLE ADMINISTRATIONS OF STABLE IODINE PROTECT POPULATION CHRONICALLY EXPOSED TO RADIOACTIVE IODINE: WHAT IS PRIODAC RESEARCH PROGRAM (2014-22) TEACHING US?. RADIATION PROTECTION DOSIMETRY, 2018, 182 (1), pp.67-79. ⟨10.1093/rpd/ncy129⟩. ⟨hal-02067478⟩

Partager

Métriques

Consultations de la notice

183